Skip to main content

Advertisement

Table 1 Clinical characteristics of type 2 diabetic subjects and control subjects

From: Serum aspirin esterase is strongly associated with glucose and lipids in healthy subjects: different association patterns in subjects with type 2 diabetes mellitus

Variables Controls (N = 20) Type 2 Diabetics (N = 27) p value
Age, years 60.1 ± 14.3 55.9 ± 10.0 0.24
Men/women, n 8/12 18/9 0.07
Body mass index, kg/m2 22.1 ± 3.7 22.8 ± 2.6 0.46
Fasting glucose, mmol/L 5.41 ± 0.79 9.13 ± 3.66 < 0.0001**
HbA1c, % 5.0 ± 0.4 7.6 ± 1.3 < 0.0001**
Total cholesterol, mmol/L 5.54 ± 1.10 5.28 ± 0.96 0.48
Triglyceride, mmol/L 1.04 (0.84-1.45) 2.11 (1.93-2.34) 0.13
HDL cholesterol, mmol/L 1.76 ± 0.41 1.40 ± 0.38 0.006**
Albumin, μmol/L 629 ± 27 605 ± 44 0.07
ChE, U/L 319 ± 73 360 ± 74 0.07
Aspirin esterase (nmol/mL/min) 39.2 (32.5-48.7) 41.6 (37.1-46.5) 0.66
  1. HbA1c: hemoglobin A1c, HDL: high-density lipoprotein, ChE: cholinesterase. Data are presented as mean ± standard deviation, median (interquartile range) or number. Triglyceride and aspirin esterase were log-transformed because of their skewed distribution in the statistical analyses. Significance level (t-test or χ2-test between the group with controls and type 2 diabetes): ** p < 0.01.